Katakura Industries (3001) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
12 Aug, 2026Executive summary
Revenue for the first half of FY2026 rose 0.4% year-over-year to ¥20,834 million, driven by growth in real estate and pharmaceuticals, offsetting declines in machinery.
Operating income increased 18.7% year-over-year to ¥3,747 million, with notable gains in real estate and fiber segments.
Net income attributable to shareholders surged 51.8% year-over-year to ¥5,371 million, boosted by gains from the sale of investment securities.
Financial highlights
Gross profit improved to ¥7,976 million from ¥7,525 million year-over-year.
Operating margin rose to 18.0% from 15.2% year-over-year.
Comprehensive income increased to ¥4,052 million, up 64.1% year-over-year.
EPS for the half-year was ¥169.68, up from ¥110.26 in the prior year.
Outlook and guidance
Full-year revenue forecast revised to ¥41,100 million, up 1.1% year-over-year.
Operating income projected at ¥5,800 million (down 0.9% year-over-year), net income at ¥7,450 million (up 29.3%).
EPS for the full year forecast at ¥235.27.
Latest events from Katakura Industries
- Profit growth outpaced revenue in Q1 FY2026, with real estate and pharma driving gains.3001
Q1 2026 - Revenue and profit fell on machinery and textile weakness, but real estate grew; dividend raised.3001
Q3 2024 - Q1 revenue and profit rose sharply, driven by machinery, with stable outlook and share buyback planned.3001
Q1 2025 - Net income surged 90.4% year-over-year, driven by machinery gains and asset sales.3001
Q3 2025 - Strong profit growth driven by machinery and real estate; cautious FY2026 outlook.3001
Q4 2025 - Revenue fell 4.7% YoY, with stable operating profit and ongoing pharma restructuring.3001
Q2 2024 - Operating and net income rose despite lower sales, with higher dividends and FY2025 growth forecast.3001
Q4 2024 - Net income nearly doubled on strong machinery sales and asset gains; full-year outlook raised.3001
Q2 2025